Zobrazeno 1 - 10
of 46
pro vyhledávání: '"W. L. Dahut"'
Autor:
Baris Turkbey, Sheri McMahon, Philip M. Arlen, W. L. Dahut, T.G. Perk, E. Mena Gonzalez, James L. Gulley, S.D. Yip, Marijo Bilusic, P. L. Choyke, Julius Strauss, Fatima Karzai, Liza Lindenberg, A.J. Weisman, Jennifer L. Marte, S. Gandhy, William D. Figg, Ravi A. Madan
Publikováno v:
Annals of Oncology. 32:S647
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbb24c8b4f9e5d11ae6ec44fad6abf7b
https://doi.org/10.1016/j.annonc.2021.08.1118
https://doi.org/10.1016/j.annonc.2021.08.1118
Autor:
S. Gandhy, Jennifer L. Marte, A. Tubbs, William D. Figg, Baris Turkbey, Sheri McMahon, Joseph D. Schonhoft, Liza Lindenberg, Ravi A. Madan, Seth M. Steinberg, A. Gill, Marijo Bilusic, P. L. Choyke, James L. Gulley, Philip M. Arlen, Fatima Karzai, Julius Strauss, E.M. Gonzales, W. L. Dahut
Publikováno v:
Annals of Oncology. 31:S527-S528
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a745a80d5d7234eaa7d2e78dede0f56
https://doi.org/10.1016/j.annonc.2020.08.902
https://doi.org/10.1016/j.annonc.2020.08.902
Autor:
Guinevere Chun, W. L. Dahut, Ravi A. Madan, Peter A. Pinto, Maria J. Merino, Esra Dikoglu, Baris Turkbey, Fatima Karzai
Publikováno v:
Cancer Research. 80:618-618
Background: In this study we report the effects of neoadjuvant enzalutamide (enza) plus androgen deprivation therapy (ADT) in the prostatectomy specimens of patients receiving this therapy, and the immunoprofile of the tumors. Prostate cancer is the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8315e946a6ce82050f9a03ceb57c9a80
https://doi.org/10.1158/1538-7445.am2020-618
https://doi.org/10.1158/1538-7445.am2020-618
Autor:
W. L. Dahut, Baris Turkbey, Maria Merino, Victoria L. Anderson, Stephanie Harmon, Hayet Amalou, Peter A. Pinto, Amel Amalou, P. L. Choyke, T. Sanford, Brad Wood, Sherif Mehralivand, Sheng Xu
Publikováno v:
Journal of Vascular and Interventional Radiology. 31:S207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f34ce4a04e936330b0cedd0c725a9d2
https://doi.org/10.1016/j.jvir.2019.12.529
https://doi.org/10.1016/j.jvir.2019.12.529
Autor:
Daniel C. Danila, Robert Dreicer, Matthew R. Smith, Emmanuel S. Antonarakis, Susan F. Slovin, Michael J. Morris, Nicolas Mottet, Glenn Liu, Daniel J. George, William Kevin Kelly, Himisha Beltran, Martin E. Gleave, Philip W. Kantoff, Karim Fizazi, Mark N. Stein, Paul G. Corn, Cora N. Sternberg, Noel W. Clarke, Dana E. Rathkopf, Michael A. Carducci, Christopher P. Evans, Axel Heidenreich, David M. Nanus, Peter S. Nelson, N.D. Shore, Mary-Ellen Taplin, W. L. Dahut, Andrew J. Armstrong, G. Wilding, Howard I. Scher, Susan Halabi, Elisabeth I. Heath
Publikováno v:
Armstrong, AJ; Antonarakis, ES; Taplin, M-E; Kelly, WK; Beltran, H; Fizazi, K; et al.(2018). Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet. ANNALS OF ONCOLOGY, 29(1), 23-25. doi: 10.1093/annonc/mdx648. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/1451t098
Annals of oncology : official journal of the European Society for Medical Oncology, vol 29, iss 1
Annals of oncology : official journal of the European Society for Medical Oncology, vol 29, iss 1
Author(s): Armstrong, AJ; Antonarakis, ES; Taplin, M-E; Kelly, WK; Beltran, H; Fizazi, K; Dahut, WL; Shore, N; Slovin, S; George, D; Carducci, MA; Corn, P; Danila, D; Dreicer, R; Heath, E; Rathkopf, D; Liu, G; Nanus, D; Stein, M; Smith, MR; Sternberg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::497ad2a9f23c0e03febf1a2efe7e80dc
http://www.escholarship.org/uc/item/1451t098
http://www.escholarship.org/uc/item/1451t098
Autor:
William D. Figg, J. Schlom, Inger L. Rosner, Jennifer L. Marte, Marijo Bilusic, Anna Couvillon, James L. Gulley, Helen Owens, Ravi A. Madan, Philip M. Arlen, Lisa M. Cordes, M. Al Harthy, Marc R. Theoret, W. L. Dahut, Amy Hankin, Julius Strauss, Fatima Karzai, Harpreet Singh
Publikováno v:
Annals of Oncology. 29:viii297
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cebaf9e0c8f8a41b9acbc21606a85210
https://doi.org/10.1093/annonc/mdy284.059
https://doi.org/10.1093/annonc/mdy284.059
Autor:
Stephen Adler, M. Liza Lindenberg, Joanna Shih, Ravi A. Madan, Sherif Mehralivand, Ethan Bergvall, Stephanie Harmon, James L. Gulley, W. L. Dahut, Peter L. Choyke, Baris Turkbey, Esther Mena
Publikováno v:
Cancer Research. 78:3671-3671
Purpose: The purpose of this study was to compare the spatial colocalization of prostate-specific membrane antigen (PSMA) targeting agent 18F-DCFBC PET/CT, a marker which demonstrates correlation with tumor aggressiveness, and 18F-NaF PET/CT, a marke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b936d72e00715d5487c99e6a752b94d
https://doi.org/10.1158/1538-7445.am2018-3671
https://doi.org/10.1158/1538-7445.am2018-3671
Autor:
David Venzon, James L. Gulley, Nima Sharifi, William D. Figg, W. L. Dahut, Romano Danesi, Tristan M. Sissung, Douglas K. Price, Akinobu Hamada, C. E. Baum
Publikováno v:
BJU International. 102:617-621
OBJECTIVE—To determine if patients with advanced prostate cancer carrying a polymorphism that codes for a more active testosterone transporter have less durable responses to androgendeprivation therapy (ADT) than patients not carrying this polymorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4462f6ba4f22296ead6970d385c58782
https://doi.org/10.1111/j.1464-410x.2008.07629.x
https://doi.org/10.1111/j.1464-410x.2008.07629.x
Autor:
H.L. Parnes, L. Linderberg, Tina Moore, M. Aviles, Mark N. Stein, Amir Mortazavi, Rene Costello, D.P. Bottaro, M. Berniger, W. L. Dahut, N. Davarpanah, Sumanta K. Pal, J. Lin, Andrea B. Apolo, Rosa Nadal, Y.M. Ning, Lisa M. Cordes, Tiffany Lancaster, Seth M. Steinberg, M. Bagheri
Publikováno v:
Annals of Oncology. 28:v295
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3aa6d6e1f8e4f72204a2d63390eee72d
https://doi.org/10.1093/annonc/mdx371.001
https://doi.org/10.1093/annonc/mdx371.001
Publikováno v:
Emerging Therapeutic Targets. 4:751-763
Prostate cancer is the most common cancer among men and is the second most common cause of cancer death. Although more patients are now diagnosed with localised prostate cancer since the advent of prostate specific antigen (PSA) screening, 30 - 40% w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2bfea8e370549f293a9dcfd41d8a0f3c
https://doi.org/10.1517/14728222.4.6.751
https://doi.org/10.1517/14728222.4.6.751